Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 25.90
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 10.54 billion as of February 13, 2026. Its market cap has increased by 4.26% in one year.
Market Cap
10.54B
Enterprise Value
5.48B
Revenue
1.47B
Ranking
n/a
PE Ratio
59.48
Stock Price
25.90
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 10.54B, a decrease of -68.36%. That is a compound annual growth rate of -23.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 10.54B | -0.50% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
| Oct 28, 2021 | 33.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HitGen | 11.92B |
| Chengdu Easton Biopharmaceuticals | 11.77B |
| Vcanbio Cell & Gene Engineering Corp., | 11.60B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 11.25B |
| Aurisco Pharmaceutical | 10.94B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.76B |
| Chengzhi | 10.56B |
| Chongqing Genrix Biopharmaceutical | 10.44B |